PDF(Pubmed)
Abstract：
UNASSIGNED: The outbreaks of infectious diseases, such as coronavirus disease 2019 (COVID-19), have seriously affected the normal work and life of the public, as well as the normal diagnosis and treatment of other diseases due to their strong infectivity, high population susceptibility, and diverse clinical manifestations. Breast and thyroid specialists in non-hotspot epidemic areas of COVID-19 must consider factors, including epidemic prevention and control, breast and thyroid cancers and diseases diagnosis and treatment, and access to medical resources to make a reasonable treatment choice and optimize the treatment process.
UNASSIGNED: A cohort study was designed under our center\'s epidemic prevention and control strategy. The study was conducted between February 3 and April 19, 2020, to explore the safety of clinical diagnosis and treatment of breast and thyroid cancer patients during the epidemic. All the outpatients, inpatients, day-time chemotherapy patients, targeted therapy patients, and relevant medical staff in the observation period in the Department of Breast and Thyroid Surgery in Southwest Hospital in Chongqing municipality, China, were included to investigate the detection and infection rate of COVID-19 and suspected patients.
UNASSIGNED: During the observation period, 27,117 patients were admitted to the outpatient unit. We performed 394 inpatient surgeries and 411 day-time surgeries. In our center, 1,046 and 663 patients received day-time chemotherapy and targeted therapy, respectively. All the patients were diagnosed and treated promptly and safely. Three suspected COVID-19 patients were identified in the outpatient unit. Healthcare staff achieved a \"zero\" infection of COVID-19.
UNASSIGNED: The spread and cross-infection of COVID-19 can be avoided in non-hotspot epidemic areas based on scientific prevention and control, and cancer patients can be diagnosed and treated on time. The prevention and control measure implemented in the COVID-19 epidemic for diagnosing and treating cancer patients was effective and can be referenced for other infectious disease outbreaks.
UNASSIGNED: A cohort study was designed under our center\'s epidemic prevention and control strategy. The study was conducted between February 3 and April 19, 2020, to explore the safety of clinical diagnosis and treatment of breast and thyroid cancer patients during the epidemic. All the outpatients, inpatients, day-time chemotherapy patients, targeted therapy patients, and relevant medical staff in the observation period in the Department of Breast and Thyroid Surgery in Southwest Hospital in Chongqing municipality, China, were included to investigate the detection and infection rate of COVID-19 and suspected patients.
UNASSIGNED: During the observation period, 27,117 patients were admitted to the outpatient unit. We performed 394 inpatient surgeries and 411 day-time surgeries. In our center, 1,046 and 663 patients received day-time chemotherapy and targeted therapy, respectively. All the patients were diagnosed and treated promptly and safely. Three suspected COVID-19 patients were identified in the outpatient unit. Healthcare staff achieved a \"zero\" infection of COVID-19.
UNASSIGNED: The spread and cross-infection of COVID-19 can be avoided in non-hotspot epidemic areas based on scientific prevention and control, and cancer patients can be diagnosed and treated on time. The prevention and control measure implemented in the COVID-19 epidemic for diagnosing and treating cancer patients was effective and can be referenced for other infectious disease outbreaks.
摘要：
■传染病的爆发，例如2019年冠状病毒病（COVID-19），严重影响了公众的正常工作和生活，以及由于其强大的传染性而对其他疾病的正常诊断和治疗，高人口易感性，和不同的临床表现。COVID-19非热点流行地区的乳腺和甲状腺专家必须考虑因素，包括流行病的预防和控制，乳腺癌和甲状腺癌以及疾病诊断和治疗，并获取医疗资源，做出合理的治疗选择，优化治疗流程。
■根据我们中心的流行病预防和控制策略设计了一项队列研究。该研究于2020年2月3日至4月19日进行，旨在探讨流行期间乳腺癌和甲状腺癌患者的临床诊断和治疗安全性。所有的门诊病人,住院病人,日间化疗患者，靶向治疗患者，以及重庆市西南医院乳腺甲状腺外科观察期间的相关医务人员，中国,调查COVID-19和疑似患者的检出率和感染率。
■在观察期间，27,117名患者被送往门诊。我们进行了394例住院手术和411例日间手术。在我们的中心,1046例和663例患者接受了日间化疗和靶向治疗，分别。所有患者均得到及时、安全的诊断和治疗。在门诊病房发现了三名疑似COVID-19患者。医护人员实现了COVID-19的“零”感染。
■在科学防控的基础上，可以避免COVID-19在非热点疫区的传播和交叉感染，癌症患者可以按时诊断和治疗。在COVID-19疫情中实施的癌症患者诊断和治疗预防控制措施是有效的，可为其他传染病暴发提供参考。
■根据我们中心的流行病预防和控制策略设计了一项队列研究。该研究于2020年2月3日至4月19日进行，旨在探讨流行期间乳腺癌和甲状腺癌患者的临床诊断和治疗安全性。所有的门诊病人,住院病人,日间化疗患者，靶向治疗患者，以及重庆市西南医院乳腺甲状腺外科观察期间的相关医务人员，中国,调查COVID-19和疑似患者的检出率和感染率。
■在观察期间，27,117名患者被送往门诊。我们进行了394例住院手术和411例日间手术。在我们的中心,1046例和663例患者接受了日间化疗和靶向治疗，分别。所有患者均得到及时、安全的诊断和治疗。在门诊病房发现了三名疑似COVID-19患者。医护人员实现了COVID-19的“零”感染。
■在科学防控的基础上，可以避免COVID-19在非热点疫区的传播和交叉感染，癌症患者可以按时诊断和治疗。在COVID-19疫情中实施的癌症患者诊断和治疗预防控制措施是有效的，可为其他传染病暴发提供参考。
